Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Endoscopic Submucosal Dissection Market Size & Growth Forecast 2026–2035, By Segments (End Use, Product, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11150| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Endoscopic Submucosal Dissection Market size was around USD 383.7 Million in 2025 and is slated to grow at a 5.6% CAGR from 2026 to 2035, crossing USD 661.65 Million by 2035. The industry revenue for 2026 is calculated at USD 402.35 million.

Base Year Value (2025)
USD 383.7 Million
CAGR (2026-2035)
5.6%
Forecast Year Value (2035)
USD 661.65 Million
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Endoscopic Submucosal Dissection Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 42.51% market share in 2025, supported by advanced endoscopy infrastructure, experienced providers, high procedural volumes, and strong adoption of specialized minimally invasive techniques.
  • Asia Pacific is projected to grow at a 6.33% CAGR, driven by rising procedural adoption, expanding endoscopic capabilities, increasing preference for minimally invasive treatment, and broader use in gastrointestinal care.

Segment Momentum

  • Hospitals held a 59.12% share in 2025 because they provide the specialized staff, advanced endoscopy infrastructure, and integrated care needed to manage diagnosis, treatment, and follow-up within one setting.
  • Knives are the fastest-growing product segment because increasing emphasis on procedural precision and operator control is driving demand for specialized instruments that improve cutting accuracy and workflow efficiency.

Market Expansion Drivers

  • Rising gastrointestinal cancer prevalence increasing demand for minimally invasive ESD procedures.
  • Advancements in endoscopic instruments improving precision and curative resection outcomes.
  • AI-assisted lesion detection and procedural planning enhancing adoption of advanced ESD platforms.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent players in the endoscopic submucosal dissection market include Olympus Corporation (Japan), Boston Scientific Corporation (United States), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), HOYA Corporation (Japan), Karl Storz SE & Co. KG (Germany), Cook Group Incorporated (United States), CONMED Corporation (United States), STERIS plc (Ireland), Creo Medical Group plc (United Kingdom).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising gastrointestinal cancer prevalence increasing demand for minimally invasive ESD procedures

Growing incidence of gastrointestinal malignancies is pushing clinicians to identify treatment options that remove early-stage lesions effectively while avoiding the morbidity, recovery burden, and hospital resource use associated with open or more extensive surgical intervention. In the endoscopic submucosal dissection market, This trends purchasing and procedural preferences toward platforms and devices that support en bloc resection of superficial tumors, particularly as screening and earlier diagnosis bring more patients into the treatment pathway at stages suitable for endoscopic management. Hospitals and specialty centers respond by expanding therapeutic endoscopy capabilities, strengthening demand for ESD knives, electrosurgical units, caps, injectables, and closure tools that enable minimally invasive cancer care.

Advancements in endoscopic instruments improving precision and curative resection outcomes

Instrument innovation is reshaping procedure economics and clinician confidence by making technically demanding dissections more controlled and reproducible. The endoscopic submucosal dissection market benefits as improved knives, traction systems, hemostatic devices, enhanced visualization components, and electrosurgical technologies reduce procedural difficulty, support cleaner margins, and help manage bleeding or perforation risk during resection. These practical gains influence adoption decisions at advanced endoscopy centers, where better curative outcomes and more predictable workflows justify investment in upgraded ESD systems and drive replacement demand for higher-performance instruments.

AI-assisted lesion detection and procedural planning enhancing adoption of advanced ESD platforms

AI-enabled imaging and decision-support tools are making complex lesion assessment more actionable at the point of care, which is increasing clinician willingness to pursue advanced endoscopic intervention rather than defer borderline cases to surgery or surveillance. In the endoscopic submucosal dissection market, AI support improves recognition of lesion boundaries, invasion patterns, and resection strategy considerations, helping physicians select appropriate candidates and prepare for technically challenging dissections with greater confidence. This strengthens adoption of integrated ESD platforms that combine high-definition visualization, image-enhancement capabilities, and software-assisted planning, especially in centers seeking to standardize outcomes as they scale therapeutic endoscopy programs.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising gastrointestinal cancer prevalence increasing demand for minimally invasive ESD procedures 2.00% High North America, Asia Pacific High Near Term
Advancements in endoscopic instruments improving precision and curative resection outcomes 1.70% Moderate North America, Europe High Mid Term
AI-assisted lesion detection and procedural planning enhancing adoption of advanced ESD platforms 1.40% Moderate Asia Pacific, Europe Emerging Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
42.51% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 42.51% share of the endoscopic submucosal dissection market. This leadership is supported by the region’s established endoscopy infrastructure, broad availability of advanced minimally invasive procedures, and the presence of healthcare providers with strong procedural expertise in complex gastrointestinal interventions. In practice, these conditions support higher procedural volumes, earlier adoption of specialized dissection tools, and more consistent integration of advanced endoscopic techniques into hospital and specialty care settings.

Asia Pacific is projected to expand at a 6.33% CAGR over the forecast period, with growth in the endoscopic submucosal dissection market being fueled by increasing procedural adoption across major healthcare systems and a rising focus on less invasive treatment approaches. The region’s momentum is aided by the growing use of endoscopic techniques in clinical practice, where providers are incorporating these procedures more actively as diagnostic and therapeutic capabilities improve. This expansion is also supported by the broader shift toward earlier intervention and endoscopy-based management pathways in routine gastrointestinal care.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Specialized Endoscopy Services

Germany is strengthening endoscopic submucosal dissection capabilities through specialized gastrointestinal centers focused on minimally invasive treatment. Healthcare providers are prioritizing advanced imaging technologies and procedural expertise to improve clinical efficiency.

France 🇫🇷

Gastrointestinal Procedure Enhancement

France is increasing the use of endoscopic submucosal dissection within specialized digestive care programs to reduce reliance on more invasive surgical approaches. Hospitals are investing in clinician expertise and precision endoscopic technologies to improve procedural consistency.

Italy 🇮🇹

Endoscopic Care Development

Italy is strengthening endoscopic submucosal dissection services by expanding access to specialized gastrointestinal treatment within hospital networks. Clinical teams are adopting advanced endoscopy platforms and focused training to improve procedural efficiency and patient care.

Japan 🇯🇵

Clinical Technique Advancement

Japan continues to refine endoscopic submucosal dissection through extensive clinical expertise and ongoing procedural innovation. Medical institutions are emphasizing advanced endoscopic technologies and specialized training to enhance treatment quality for gastrointestinal conditions.

South Korea 🇰🇷

Endoscopy Innovation Adoption

South Korea is expanding endoscopic submucosal dissection across tertiary hospitals as demand grows for minimally invasive gastrointestinal interventions. Healthcare providers are integrating advanced endoscopic systems that improve procedural accuracy and clinical workflow efficiency.

United States 🇺🇸

Advanced Minimally Invasive Care

U.S. healthcare providers are expanding endoscopic submucosal dissection procedures to improve treatment options for early gastrointestinal lesions. Hospitals are investing in specialized endoscopic equipment and physician training to support procedural precision and patient outcomes.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Endoscopic Submucosal Dissection Market Share (%), End Use, 2025

Hospitals
Specialty Clinics
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)

Hospitals held a 59.12% share of the endoscopic submucosal dissection market in 2025, and this setting continues to show the strongest growth momentum because it concentrates the clinical infrastructure, specialist staff, and procedural support that these interventions require. Endoscopic submucosal dissection is typically performed in environments equipped for advanced endoscopy, patient monitoring, pathology coordination, and management of procedural complexity, which keeps hospitals at the center of case volumes. Their continued expansion within the endoscopic submucosal dissection market is also backed by the rising preference for integrated care pathways where diagnosis, resection, complication management, and follow-up can be handled within a single institution.

Product Segment Analysis: Gastroscopes and Colonoscopes (Largest Segment) vs Knives (Fastest-Growing Segment)

Within the endoscopic submucosal dissection market, gastroscopes and colonoscopes accounted for a 33.92% share in 2025, reflecting their core role as the primary procedural platforms used to visualize lesions, navigate anatomy, and enable therapeutic access. Their leadership is maintained through the fact that no endoscopic submucosal dissection procedure can be performed without these systems, making demand closely tied to installed endoscopy capacity and routine procedural throughput across treatment centers. This foundational role keeps gastroscopes and colonoscopes at the center of purchasing and replacement cycles in the market.

Knives are the fastest-growing product segment in the endoscopic submucosal dissection market because procedural precision and operator control are central to successful mucosal and submucosal resection. As providers place greater emphasis on technique-specific performance during dissection, demand is rising for specialized knives that better support cutting accuracy and workflow efficiency during complex cases. Compared with broader capital equipment categories, this segment gains momentum from direct alignment with procedural execution, making it more responsive to evolving practice requirements in endoscopic submucosal dissection.

Segment Sub-Segment Largest Segment Fastest Growing
End Use Hospitals, Specialty Clinics, Others Hospitals Hospitals
Product Gastroscopes and Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers/ Clips, Others Gastroscopes and Colonoscopes Knives
Indication Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Others Gastric Cancer Colorectal Cancer
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the endoscopic submucosal dissection market:

1. Olympus Corporation (Japan)

2. Boston Scientific Corporation (United States)

3. Medtronic plc (Ireland)

4. FUJIFILM Holdings Corporation (Japan)

5. HOYA Corporation (Japan)

6. Karl Storz SE & Co. KG (Germany)

7. Cook Group Incorporated (United States)

8. CONMED Corporation (United States)

9. STERIS plc (Ireland)

10. Creo Medical Group plc (United Kingdom)

Technological refinement in minimally invasive procedures is significantly influencing the endoscopic submucosal dissection market. Advanced visualization systems, precision instruments, and ergonomic device designs are being developed to improve procedural efficiency and patient safety. Continued investment in clinical research and procedural training is also supporting wider adoption of sophisticated endoscopic treatment techniques.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Olympus May-26 Olympus entered a global distribution collaboration with EndoRobotics to integrate robot-assisted endoscopic systems into its portfolio. This partnership significantly expands the company’s presence in next-generation, minimally invasive gastrointestinal surgical technologies and provides a scalable distribution channel for advanced endoscopic procedural solutions.
EndoQuest Robotics Sep-25 EndoQuest Robotics completed the first fully robotic endoscopic submucosal dissection using its proprietary endoluminal system. This clinical milestone validates the operational viability of robotic-assisted gastrointestinal surgery and represents a significant technical advancement toward commercializing autonomous or semi-autonomous platforms for complex minimally invasive interventions.
Olympus Sep-25 Olympus launched the OLYSENSE CAD/AI portfolio in the U.S. and European markets, providing cloud-based, AI-powered tools for real-time lesion detection. This integration of artificial intelligence into endoscopy workflows enhances diagnostic accuracy and operational efficiency, reflecting the company's strategic push to digitize and improve clinical outcomes in complex gastrointestinal procedures.
EndoQuest Robotics Jul-25 EndoQuest Robotics secured a Series D-2 funding round led by Crescent Enterprises and Dr. Fred Moll. This capital injection is earmarked for accelerating clinical trials and regulatory approval processes for its robotic endoluminal surgical system, directly supporting the commercialization trajectory of new robotic technologies for gastrointestinal and endoluminal surgery.
Fujifilm Jul-25 Fujifilm launched the ELUXEO 8000 system and 800 Series endoscopes, upgrading its high-performance imaging platform for gastrointestinal procedures. The launch reinforces the company’s competitive positioning in advanced visualization, providing clinicians with improved imaging capabilities essential for the precision required in complex endoscopic submucosal dissection and related therapeutic interventions.
Fujifilm Apr-24 Fujifilm introduced the Tracmotion device, an endoscopic tool designed for single-operator use in ESD procedures. Featuring 360° rotatable retraction, the device addresses critical functional challenges in tissue manipulation during complex dissections, representing a targeted innovation to improve procedural efficiency and clinical outcomes in advanced gastrointestinal surgeries.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Endoscopic Submucosal Dissection Market — Custom Segments

Segment Sub-Segment
No segment data available.

Endoscopic Submucosal Dissection Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the endoscopic submucosal dissection market?

As of 2026 the market size of endoscopic submucosal dissection is valued at USD 402.35 million.

How is the endoscopic submucosal dissection industry size expected to evolve during the forecast period?

Endoscopic Submucosal Dissection Market size is forecasted to reach USD 661.65 million by 2035 rising from USD 383.7 million in 2025 at a CAGR of more than 5.6% between 2026 and 2035.

How is rising gastrointestinal cancer prevalence driving adoption of minimally invasive endoscopic submucosal dissection procedures?

Increasing gastrointestinal cancer cases are pushing demand for minimally invasive ESD procedures that enable en bloc tumor removal. This reduces surgical morbidity and hospital resource use while expanding demand for specialized endoscopic devices and therapeutic platforms in early-stage treatment pathways.

How are advancements in endoscopic instruments improving adoption and clinical outcomes in ESD procedures?

Improved knives, visualization systems, and hemostatic tools are enhancing precision and reducing procedural risks. These advancements improve clinician confidence, enable cleaner resections, and support broader adoption of ESD platforms in advanced therapeutic endoscopy centers.

Why are hospitals the leading end-use segment in the endoscopic submucosal dissection market?

Hospitals held a 59.12% share in 2025 because they provide the specialized staff, advanced endoscopy infrastructure, and integrated care needed to manage diagnosis, treatment, and follow-up within one setting.

Why are knives the fastest-growing product segment in the endoscopic submucosal dissection market?

Knives are the fastest-growing product segment because increasing emphasis on procedural precision and operator control is driving demand for specialized instruments that improve cutting accuracy and workflow efficiency.

What supports North America's leadership in the endoscopic submucosal dissection market?

North America held a 42.51% market share in 2025, supported by advanced endoscopy infrastructure, experienced providers, high procedural volumes, and strong adoption of specialized minimally invasive techniques.

Why is Asia Pacific emerging as the fastest-growing endoscopic submucosal dissection market?

Asia Pacific is projected to grow at a 6.33% CAGR, driven by rising procedural adoption, expanding endoscopic capabilities, increasing preference for minimally invasive treatment, and broader use in gastrointestinal care.

Which companies are driving growth in the endoscopic submucosal dissection landscape?

Prominent players in the endoscopic submucosal dissection market include Olympus Corporation (Japan), Boston Scientific Corporation (United States), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), HOYA Corporation (Japan), Karl Storz SE & Co. KG (Germany), Cook Group Incorporated (United States), CONMED Corporation (United States), STERIS plc (Ireland), Creo Medical Group plc (United Kingdom).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →